HIV patients on medication who keep taking tesamorelin for a year continue to have less belly fat, lower triglycerides, and better cholesterol levels compared to when they started. This finding is from the abstract summary - full study details were not available

A drug called tesamorelin helps reduce belly fat deep inside the abdomen for people with HIV who are on medication, making their belly fat decrease by about 15% compared to those not taking the drug. This finding is from the abstract summary - full study details were not available

Tesamorelin improves the ratio of bad cholesterol to good cholesterol by about 7% in HIV patients on medication, which is better for heart health. This finding is from the abstract summary - full study details were not available

A drug called tesamorelin helps HIV patients with belly fat buildup lose about 11% of their dangerous internal belly fat in six months, while those on a dummy pill lose almost none.

Continuing tesamorelin for a full year helps HIV patients with belly fat lose nearly 18% of their dangerous internal belly fat, with no loss of benefit over time.

If HIV patients stop taking the injection, the belly fat they lost comes right back quickly.